Aravive, Inc. Uncategorized Contracts & Agreements
44 Contracts & Agreements
- Offer Letter, dated April 10, 2023, by and between Aravive, Inc. and Maria Carolina Petrini (Filed With SEC on April 11, 2023)
- Description of Capital Securities (Filed With SEC on March 15, 2023)
- Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Leonard Scott Dove, Ph.D (Filed With SEC on February 6, 2023)
- Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Robert Geller, M.D (Filed With SEC on February 6, 2023)
- Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and RudyHoward (Filed With SEC on February 6, 2023)
- Amendment No. 3 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Gail McIntyre, Ph.D (Filed With SEC on February 6, 2023)
- Form of Side Letter Agreement by and among Aravive, Inc. and the BVF Investor party thereto (Filed With SEC on October 26, 2022)
- Form of Side Letter Agreement by and among Aravive, Inc. and the persons party thereto (Filed With SEC on October 26, 2022)
- Offer Letter, dated June 13, 2022, by and between Aravive, Inc. and Dr. Robert B. Geller (Filed With SEC on July 5, 2022)
- Offer Letter, dated June 2, 2022, by and between Aravive, Inc. and Rudy C. Howard (Filed With SEC on June 3, 2022)
- Offer Letter between Leonard Scott Dove, Ph.D. and Aravive, Inc (Filed With SEC on March 22, 2022)
- Offer Letter, dated September 8, 2020 between Reshma Rangwala and the Company (Filed With SEC on March 16, 2021)
- Description of Capital Securities (Filed With SEC on March 16, 2021)
- Amendment to Offer Letter dated as of January 25, 2021 by and between Aravive, Inc. and Gail McIntyre, Ph.D (Filed With SEC on January 27, 2021)
- Amendment to Offer Letter dated as of April 8, 2020 by and between the Company and Gail McIntyre (Filed With SEC on April 9, 2020)
- Option Agreement dated April 8, 2020 by and between the Company and Robert Hoffman (Filed With SEC on April 9, 2020)
- Option Agreement dated April 8, 2020 by and between the Company and Jay Shepard (Filed With SEC on April 9, 2020)
- Option Agreement dated April 8, 2020 by and between the Company and Srini Akkaraju (Filed With SEC on April 9, 2020)
- Offer Letter, dated March 26, 2020 between Gail McIntyre and Aravive, Inc (Filed With SEC on March 27, 2020)
- Offer Letter, dated March 26, 2020, between Vinay Shah and Aravive, Inc (Filed With SEC on March 27, 2020)
- Description of Capital Securities (Filed With SEC on March 27, 2020)
- Offer Letter, dated January 8, 2020, between Rekha Hemrajani and Aravive, Inc (Filed With SEC on January 9, 2020)
- Amendment to Jay Shepard Offer Letter dated as of February 28, 2019 (Filed With SEC on March 6, 2019)
- Offer Letter dated January 1, 2017 by and between Aravive Biologics, Inc. and Gail McIntyre (Filed With SEC on February 12, 2019)
- Offer Letter dated February 1, 2017 and the amendment thereto dated May 30, 2018 by and between Aravive Biologics, Inc. and Vinay Shah (Filed With SEC on February 12, 2019)
- Amendment to Jay Shepard Offer Letter dated as of February 6, 2019 (Filed With SEC on February 12, 2019)
- Cancer Research Grant Contract, dated December 1, 2015, by and between the Cancer Prevention and Research Institute of Texas and Ruga Corporation (Filed With SEC on August 3, 2018)
- Form of Support Agreement, by and between Aravive Biologics, Inc. and Versartis, Inc.s directors, officers and certain stockholders (Filed With SEC on June 4, 2018)
- Form of Support Agreement, by and between Versartis, Inc. and Aravive Biologics, Inc.s directors, officers and certain stockholders (Filed With SEC on June 4, 2018)
- Offer Letter with Robert Gut, dated August 30, 2017 (Filed With SEC on March 6, 2018)
- AMUNIX OPERATING INC. 500 Ellis Street Mountain View, CA 94043 (Filed With SEC on August 7, 2017)
- Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 02/16/2016 (Filed With SEC on May 4, 2016)
- Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 02/27/2015 (Filed With SEC on May 4, 2016)
- Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 May 12, 2015 (Filed With SEC on August 5, 2015)
- 4200 Bohannon Drive, Suite 250 | Menlo Park, CA 94025 | 650 ###-###-#### (main) (Filed With SEC on August 5, 2015)
- TECHNOLOGY TRANSFER AND CLINICAL SUPPLYAGREEMENT (Filed With SEC on March 19, 2014)
- AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED LICENSING AGREEMENT (Filed With SEC on March 6, 2014)
- VERSARTIS, INC. 500 ELLIS STREET MOUNTAIN VIEW, CA 94043 February 10, 2011 (Filed With SEC on February 18, 2014)
- VERSARTIS, INC. 275 SHORELINE DRIVE, SUITE 450 REDWOOD CITY, CA 94065 November 8, 2013 (Filed With SEC on February 18, 2014)
- VERSARTIS, INC. December 20, 2010 (Filed With SEC on February 18, 2014)
